 The purpose of this study is to determine that Transcatheter aortic valve replacement TAVR with SAPIEN 3 is superior to traditional surgical aortic valve replacementSAVR with bio-prosthesis regarding the rate of all-cause mortality at 1 year in patients with symptomatic severe aortic valve stenosis. 